Details for Patent: 12,263,158

Which drugs does patent 12,263,158 protect, and when does it expire?

Patent 12,263,158 protects ONTRALFY and is included in one NDA.

This patent has ten patent family members in seven countries.

Summary for Patent: 12,263,158

Title:	Tizanidine liquid preparation and use thereof
Abstract:	A tizanidine liquid preparation and use of the tizanidine liquid preparation in the preparation of a medicament for treating muscle spasm, wherein the tizanidine liquid preparation comprises an active ingredient, disodium EDTA and other pharmaceutical excipients, wherein the active ingredient is one or more of tizanidine or a pharmaceutically acceptable salt, solvate and hydrate thereof.
Inventor(s):	Gang Chen, Gongzheng CHEN, Song Lin, Rashmi Rohit PRASADE, Ganesh Dattatray CHAVAN PATIL
Assignee:	Fidelity Biopharma Co
Application Number:	US17/918,130
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Dosage form;

Drugs Protected by US Patent 12,263,158

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Fidelity Biopharma	ONTRALFY	tizanidine hydrochloride	SOLUTION;ORAL	216190-001	Dec 12, 2024		RX	Yes	Yes	12,263,158		Y			TREATMENT OF SPASTICITY

International Family Members for US Patent 12,263,158

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2022280757
Canada	3221397
China	115400123